Current data suggest that the human immunodeficiency virus type 1 (HIV-1) epidemic arose by transmission of simian immunodeficiency virus (SIV) SIVcpz from a subspecies of common chimpanzees (Pan troglodytes troglodytes) to humans. SIVcpz of chimpanzees is itself a molecular chimera of SIVs from two or more different monkey species, suggesting that recombination was made possible by coinfection of one individual animal with different lentiviruses. However, very little is known about SIVcpz transmission and the susceptibility to lentivirus coinfection of its natural host, the chimpanzee. Here, it is revealed that either infected plasma or peripheral blood mononuclear cells readily confer infection when exposure occurs by the intravenous or mucosal route. Importantly, the presence of preexisting HIV-1 infection did not modify the kinetics of SIVcpz infection once it was established by different routes. Although humoral responses appeared as early as 4 weeks postinfection, neutralization to SIVcpz-ANT varied markedly between animals. Analysis of the SIVcpz env sequence over time revealed the emergence of genetic viral variants and persistent SIVcpz RNA levels of between 104 and 105 copies/ml plasma regardless of the presence or absence of concurrent HIV-1 infection. These unique data provide important insight into possible routes of transmission, the kinetics of acute SIVcpz infection, and how readily coinfection with SIVcpz and other lentiviruses may be established as necessary preconditions for potential recombination.
Introduction
Chimpanzees (Pan troglodytes troglodytes and Pan troglodytesschweinfurthii) harbor various genetically different strains of simian immunodeficiency virus (SIV) SIVcpz (20, 30, 34) .These variants exhibit molecular similarity to human immunodeficiency virus type 1 (HIV-1) isolates belonging to clades M,N, and O, suggesting that at least three multiple cross-species transmission events have occurred in the past (11, 13, 31) .Evidence that SIVs can cause AIDS following cross-species transmission has been most clearly illustrated by SIV transmission from asymptomatic African sooty mangabeys (SIVsm) to Asian macaques (6, 18, 22) . Furthermore, there is a convincing body of data showing that SIVsm is the nonhuman primate lentivirus ancestor of HIV-2 (16, 21) . More than 35 African nonhuman primate species have been reported to carry a variety of different lentiviruses (29) . The majority of SIVs infect monkeys, and to date, only SIVcpz of chimpanzees is known among the great apes.
Genetic analysis of diverse SIVcpz isolates from two subspecies of chimpanzees
indicates that the ancestor of SIVcpz is most probably a recombinant chimeric virus derived from viruses found in monkey species known to be preyed upon by chimpanzees (1, 35) . The SIVcpz gag-pol region shows high sequence similarity with SIVrcm of the red-capped mangabey(Cercocebus torquatus), whereas env is related to the sequenceof the SIVs found in the greater spot-nosed monkey (Cercopithecusnictitans) lineage (1) . The most plausible explanation for the occurrence of this recombinant virus is that at least one chimpanzee became infected with one of these two viruses and subsequently became superinfected or coinfected with a second monkey lentivirus. It is likely that in the absence of persistent monkey lentiviral infections in chimpanzees, the recombinant ancestors of SIVcpz now circulating in today's populations of chimpanzees acquired the ability to both persist and sustain sufficient plasma virus loads in vivo to be effectively transmitted between individuals of this species. Thus, the sustained dual infection of chimpanzees by one or more distinct monkey SIVs must have been a necessary prerequisite for the recombinatory events which provided the chimeric origin of SIVcpz. In this paper, we present novel data on potential routes of transmission and the acute infection period of SIVcpz, providing fundamental and important insights into the natural history of the ancestor of HIV-1 in the common chimpanzee. Furthermore, we provide direct evidence that secondary lentivirus coinfections can be readily acquired by chimpanzees.
To date, only a limited number of chimpanzees living in captivity have been identified with naturally occurring SIVcpz infections (24) . One such chimpanzee was rescued following illegal export from Africa. This animal, ch-No, provided a unique opportunity for virological and immunological follow-up of a natural SIV infection (28, 30, 32) . The apparent low prevalence of SIVcpz infection is due to SIVcpz's focal epidemiology, which is relatively high in specific regions and communities of wild chimpanzee populations compared to others (24, 34) . The reasons for this are unclear, but it may be due to the dynamics of transmission and social interactions among individual chimpanzees in their communities. Indeed, the modes of SIVcpz transmission in chimpanzees are unknown, and the patterns of transmission may be different than that of HIV-1 in humans.
To address the question of SIVcpz transmission, a series of studies were undertaken in a naive chimpanzee from the host subspecies, P. t. schweinfurthii, and in a cohort of captive bred chimpanzees previously designated for the study of HIV-1 infection and pathogenesis. These studies revealed that SIVcpz infection could be readily established with either plasma or peripheral blood mononuclear cells (PBMCs) by several different routes independently of the presence of concurrent HIV-1 infection.
We show that the early kinetics of SIVcpz infection are similar to those of HIV-1 infection in humans with respect to seroconversion, high levels and persistence of plasma viremia, the development of neutralizing antibody responses, and the evolution of individual sequence variants in plasma. In contrast to humans, the infection in chimpanzees differed in the absence of immune activation, the lack of progressive CD4 T-cell loss, and the development of AIDS despite coinfection with HIV-1.
Materials and Methods

Animals and longitudinal-study design.
The study group consisted of a total of nine chimpanzees (Pan troglodytes), three of which were P. t. schweinfurthii. One (ch-No) of these animals was naturally infected with SIVcpz-ANT; another (ch-Ni) was a seronegative cage mate at risk of infection. Table 1 ). All of the animals were mature and in good health with normal hematological values. The six HIV-1-infected animals had low or undetectable virus loads (below 50 copies/ml plasma), common in HIV-1-infected chimpanzees. Prior to initiating any in vivo procedures, the study protocols were evaluated by independent ethical committees in accordance with national and international regulations (International Animal Care and Use Committee). The study design was developed after prolonged observation of the two P. t. schweinfurthii animals, ch-Ni and ch-No. For social and behavioral reasons, these two animals were housed together despite the fact that ch-No was infected with SIVcpz. The development of a specific quantitative PCR to detect SIVcpz infection confirmed these results (38) . During a 5-year observation period, the two male animals became sexually active, and incidents of aggression in which blood was drawn began to increase. It was determined that transmission of SIVcpz infection to the negative cage mate was a question of time, and ethical permission to acquire valuable early SIVcpz infection data in a carefully monitored prospective study was granted. To study the kinetics of SIVcpz infection in P. t. schweinfurthii, the decision was taken to iatrogenically transfer PBMCs intravenously from the naturally infected chronic carrier of SIVcpz-ANT, ch-No. RNA copies/ml). These ex vivo uncultured stocks were used for subsequent transmission studies of clade B HIV-1-infected or uninfected chimpanzees, as indicated in Table 1 . The virus was titrated in parallel with the neutralization assay to estimate the actual input under the prevailing experimental conditions. Viral antigen release into culture supernatants was monitored by an in-house enzymelinked immunosorbent assay (ELISA) (4). Optical densities were used to calculate concentrations of released SIVcpz-specific antigen against a standard curve generated with dilutions of SIVcpz-ANT cultured in human PBMCs. The results are given in log10 of arbitrary units of viral antigen (27) .
To define statistically significant neutralization, an analysis of variance was performed on the log10-transformed antigen release data from all cultures following incubation of virus with a pretransmission plasma and four posttransmission plasmas.
The statistical significance of the F ratio of the variance between the plasma divided by the variance between the individual cultures is reported for each chimpanzee. The individual plasmas that were neutralizing were identified by reference to the minimum significant range calculated from the variance between the cultures and a constant derived from tables for the Studentized range test and depending on numbers of cultures and samples to be compared (7, 9) .
Flow cytometric analysis of lymphocyte subsets
White blood cell and platelet counts were performed with a Technicon H1 (Technicon Instruments, Tarrytown 
Analysis of viral quasispecies.
To determine the viral quasispecies, we performed PCR on viral RNA that was isolated from plasma samples or on genomic DNA isolated from PBMCs.
The V1-V3 envelope region was amplified by a nested PCR using the following 
Phylogenetic analysis
Nucleotide sequences were aligned using ClustalW as incorporated in the MacVector 8.1.1 sequence analysis software package (Accelrys, Cambridge, United Kingdom), and the aligned sequences were manually edited. Phylogenetic analysis was performed with PAUP* version 4.0b10 (37) by using the maximum likelihood (ML) method. To determine the best model of evolution for the alignments, FINDMODEL was used (http://www.hiv.lanl.gov /content/hiv-db/findmodel/findmodel.html). The optimal models General Time Reversible plus Gamma and Hasegawa-Kishino-Yano plus Gamma were then used to construct the optimal ML trees.
The reliability of the branching orders was tested using the bootstrap approach as implemented by PAUP* for 1,000 replicates.
Results
Transmission and early kinetics of SIVcpz infection
Confirmation that ch-Ni was infected following i.v. exposure to his infected cage mate's (ch-No) PBMCs was provided by a characteristic pattern of seroconversion on a Western blot, where between weeks 4 and 6, antibodies first binding to structural
Gag and Env proteins appeared in a pattern common to that observed in HIV-1-infected humans (Fig. 1B) . Results were confirmed by ELISA using HIV-1 antigens (data not shown). copies/ml, which declined rapidly during the seroconversion period and subsequently reached threshold levels similar to those observed in ch-No (Fig. 1A) . To determine the effect of acute SIVcpz infection on CD4 T cells and other subsets, a detailed longitudinal analysis was undertaken. Interestingly, in the immediate postinfection period, a minor decline in both CD4 T cells and NK subsets was observed, but fluctuations remained within normal limits (Fig. 2) . Similarly, a transient decline in the B-cell subset was apparent within 5 weeks of infection. All lymphocyte subsets remained in the normal range up to 70 weeks postinfection. No evidence of thrombocytopenia or anemia has been observed in this animal to date.
FIG. 2. Absolute lymphocyte counts. Whole blood of ch-Ni was analyzed for specific lymphocyte subsets. □ CD4 T-cells; Δ CD8 T-cells; • NK cells; ▼ B cells.
SIVcpz superinfection in the presence of HIV-1
In contrast to the chimpanzee subspecies P. To determine if SIVcpz was capable of establishing infection despite the presence of preexisting HIV-1 infection, two HIV animals were exposed i.v. to an excess number of freshly cryopreserved PBMCs, established as a stock from ch-Ni in the acute infection phase. The two HIV-1IIIB-infected chimpanzees, ch-X062 and ch-X310, were readily infected by SIVcpz as determined by quantity-controlled PCR (Fig. 3) .
Intravenous exposure resulted in the rapid appearance of SIVcpz RNA in plasma.
Interestingly, despite the rapid establishment of SIVcpz infection and the development of steady-state plasma RNA levels comparable to those of ch-No and ch-Ni (Fig. 3) , the peak viral load was at least 1 log unit less than in the natural P. t. schweinfurthii host. One animal (ch-X310) had detectable HIV-1 viral loads in plasma prior to SIVcpz superinfection (approximately 10 3 RNA eq/ml), which declined below detection levels (40 copies/ml) during the acute phase of SIVcpz infection (Fig. 3) .
Having demonstrated that SIVcpz superinfection could occur by i.v. exposure with superinfection. In addition, a naıve control animal was added to the group and exposed at the same time to rule out possible effects of preexisting HIV infection.
None of the animals were in estrus at the time of administration and were estimated by the attending veterinarian to be at similar stages of their cycles. However, as seen in Fig. 3 , only the HIV-1-naı¨ve animal, ch-X284, became infected, while the two HIV-1-infected animals resisted vaginal exposure to the same combination of infected plasma and PBMCs. 
Lack of evidence for progression to AIDS after primary or secondary SIVcpz infection
Detailed longitudinal fluorescence-activated cell sorter analysis failed to reveal any evidence of progression to AIDS in the study animals. Interestingly, while absolute CD4 T-cell levels appeared to subtly and transiently decline following i.v. and i.r.
infection (Fig. 4A) , the effect was not observed in the i.vag.-infected previously HIV-1-naı¨ve animal, ch-X284 (Fig. 4A) . CD8 T-cell levels were not influenced by HIV/SIVcpz coinfection (Fig. 4B) . These results were in agreement with normal uninfected chimpanzee values and did not differ from previous follow-up studies (15, 32) . 
Kinetics of neutralizing-antibody development
Plasma taken from five of the HIV-1-infected chimpanzees before their exposure to SIVcpz produced a 50 to 90% reduction in antigen release. The exception was ch-X062, where no reduction was observed. However, none of the reductions reached statistical significance.
Both the chimpanzees challenged by the intravenous route developed statistically significant neutralization: X62 by week 6 and X310 by week 24 (Fig. 5) . The intrarectally challenged chimpanzee, X176, also developed statistically significant neutralization by week 6. In contrast, X115 did not show a neutralizing-antibody response at any time (final observation was at week 46). Of the female chimpanzees, 
Analysis of viral variation following transmission of SIVcpz
To determine which viral variants were transferred to ch-Ni after experimental infection with PBMCs from ch-No, we determined the quasispecies in the viral inoculum from ch-No and in the blood sample taken from ch-Ni 2 weeks posttransmission (Fig. 6A) . From ch-No and ch-Ni, we analyzed 11 and 15 clones, respectively, each spanning the V1-V5 region. (Fig. 6B ).
Discussion
The transmission of SIVcpz from chimpanzees to humans is the leading hypothesis The early kinetics of SIVcpz infection in many ways were similar to HIV-1 infection in humans. Peak plasma concentrations of SIVcpz RNA were mirrored by plasma antigen peaks at 2 weeks, which then declined to low or undetectable levels as animals began to seroconvert. Furthermore, evidence of immune complex formation between SIVcpz and antibodies was documented by acid dissociation, and using this technique, plasma antigen could be detected for a longer period in ch-Ni.
Interestingly, similar to HIV-1 in humans, animals infected with SIVcpz seroconvert early to the Gag antigen. However, this observation differs from the other relatively well-studied natural SIV infections of African green monkeys (SIVagm) and sooty mangabeys (SIVsm), which frequently fail to seroconvert to Gag and are proposed to be tolerant of that antigen (19) . The development of neutralizing antibodies was Furthermore, it was revealed that SIVcpz can be readily transmitted to other subspecies of chimpanzees not known to carry SIVcpz and it was demonstrated that they too remain asymptomatic. The relative resistance of chimpanzees to the development of AIDS was again observed in the absence of immune activation and overt CD4 T-cell loss in the face of high levels of persistent plasma lentiviremia (12) .
Finally, these findings demonstrate how easily HIV-1-related lentivirus super-or coinfections are established without any apparent impact of adaptive responses on plasma virus loads. Although evidence of recombination has not yet been found, these findings provide evidence for the necessary preconditions upon which they may arise. 
